地氟烷对围术期心肌保护作用的研究进展
Research Progress of Desflurane on Perioperative Myocardial Protection
DOI: 10.12677/ACM.2022.12101312, PDF,    国家自然科学基金支持
作者: 智嘉浩:天津医科大学一中心临床学院,天津;盛明薇, 贾莉莉, 翁亦齐, 喻文立*:天津市第一中心医院麻醉科,天津
关键词: 地氟烷挥发性麻醉药心肌保护心肌损伤Desflurane Volatile Anesthetics Myocardial Protection Myocardial Injury
摘要: 地氟烷是一种挥发性麻醉药,其心脏保护机制与线粒体及抗凋亡信号通路有关。动物实验和人体研究已经证明,在心脏手术中使用它们可以降低发病率和死亡率,包括减少心肌梗死面积和机械通气时间。一些研究通过减少心肌损伤生化标记物的释放表明其具有保护心肌功能的作用,同时,可以降低心血管术后并发症和死亡率,对术后转归也有一定帮助。本文总结了地氟烷参与心肌保护的可能机制以及对临床结果的观察归纳总结。
Abstract: Desflurane is a volatile anesthetic, and its cardioprotective mechanism is related to mitochondria and anti-apoptotic signaling pathway. Animal experiments and human studies have demonstrated that their use in cardiac surgery reduces morbidity and mortality, including a reduction in myocar-dial infarct size and mechanical ventilation time. Some studies have shown that it has a protective effect on myocardial function by reducing the release of biochemical markers of myocardial injury. At the same time, it can reduce the complications and mortality after cardiovascular surgery, and it is also helpful for the postoperative outcome. This article summarizes the possible mechanism of desflurane in myocardial protection and the observation and summary of clinical results.
文章引用:智嘉浩, 盛明薇, 贾莉莉, 翁亦齐, 喻文立. 地氟烷对围术期心肌保护作用的研究进展[J]. 临床医学进展, 2022, 12(10): 9070-9080. https://doi.org/10.12677/ACM.2022.12101312

参考文献

[1] Stroda, A., et al. (2022) Incidence and Prognosis of Myocardial Injury in Patients with Severe Trauma. European Jour-nal of Trauma and Emergency Surgery, 48, 3073-3079. [Google Scholar] [CrossRef] [PubMed]
[2] Tor-regroza, C., Raupach, A., Feige, K., et al. (2020) Perioperative Cardioprotection: General Mechanisms and Pharmacolog-ical Approaches. Anesthesia & Analgesia, 131, 1765-1780. [Google Scholar] [CrossRef
[3] Answine, J.F. (2021) Desflurane Should Not Des-Appear. Anesthesia & Analgesia, 132, E41-E42. [Google Scholar] [CrossRef
[4] Lemoine, S., et al. (2016) The Mechanisms of Car-dio-Protective Effects of Desflurane and Sevoflurane at the Time of Reperfusion: An Aesthetic Post-Conditioning Poten-tially Translatable to Humans? British Journal of Anaesthesia, 116, 456-475. [Google Scholar] [CrossRef] [PubMed]
[5] Ponikowski, P., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129-2200. [Google Scholar] [CrossRef] [PubMed]
[6] Head, S.J., et al. (2013) The European Association for Car-dio-Thoracic Surgery (EACTS) Database: An Introduction. European Journal of Cardio-Thoracic Surgery g, 44, E175-E180. [Google Scholar] [CrossRef] [PubMed]
[7] Safdar, B., et al. (2018) Presentation, Clinical Profile, and Prognosis of Young Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Results from the VIRGO Study. Journal of the American Heart Association, 7, e009174. [Google Scholar] [CrossRef
[8] Piccolo, R., et al. (2015) Stable Coronary Artery Disease: Revas-cularisation and Invasive Strategies. The Lancet, 386, 702-713. [Google Scholar] [CrossRef
[9] Chen, S., et al. (2018) Comparison of Volatile Anesthet-ic-Induced Preconditioning in Cardiac and Cerebral System: Molecular Mechanisms and Clinical Aspects. European Journal of Medical Research, 23, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[10] Zangrillo, A., et al. (2022) Effect of Volatile Anesthetics on My-ocardial Infarction after Coronary Artery Surgery: A Post Hoc Analysis of a Randomized Trial. Journal of Cardiotho-racic and Vascular Anesthesia, 36, 2454-2464. [Google Scholar] [CrossRef] [PubMed]
[11] Caricati-Neto, A., Errante, P.R. and Menezes-Rodrigues, F.S. (2019) Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection. International Journal of Molecular Sciences, 20, Article No. 4002. [Google Scholar] [CrossRef] [PubMed]
[12] Pagel, P.S., et al. (1991) Comparison of the Systemic and Coronary Hemodynamic Actions of Desflurane, Isoflurane, Halothane, and En-flurane in the Chronically Instrumented Dog. Anesthesiology, 74, 537-551. [Google Scholar] [CrossRef] [PubMed]
[13] Thomson, I.R., et al. (1991) A Comparison of Desflu-rane and Isoflurane in Patients Undergoing Coronary Artery Surgery. Anesthesiology, 75, 776-781. [Google Scholar] [CrossRef] [PubMed]
[14] Ozarslan, N.G., et al. (2012) Comparison of the Effects of Sevoflurane, Isoflurane, and Desflurane on Microcirculation in Coronary Artery Bypass Graft Surgery. Journal of Cardiothoracic and Vascular Anesthesia, 26, 791-798. [Google Scholar] [CrossRef] [PubMed]
[15] Kunst, G. and Klein, A.A. (2015) Peri-Operative Anaesthetic My-ocardial Preconditioning and Protection-Cellular Mechanisms and Clinical Relevance in Cardiac Anaesthesia. Anaesthesia, 70, 467-482. [Google Scholar] [CrossRef] [PubMed]
[16] Landoni, G., et al. (2019) Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery. New England Journal of Medicine, 380, 1214-1225. [Google Scholar] [CrossRef
[17] Heiberg, J., et al. (2018) Propofol Attenuates the Myocardial Pro-tection Properties of Desflurane by Modulating Mitochondrial Permeability Transition. Anesthesia & Analgesia, 127, 387-397. [Google Scholar] [CrossRef
[18] Stefan, G. and Stefanie, C. (2003) Effects of Propofol, Des-flurane, and Sevoflurane on Recovery of Myocardial Function after Coronary Surgery in Elderly High-Risk Patients. Anesthesiology, 99, 314-323. [Google Scholar] [CrossRef] [PubMed]
[19] Sivanna, U., et al. (2015) A Comparative Study of Pharmacological Myocardial Protection between Sevoflurane and Desflurane at Anaesthestic Doses in Patients Undergo-ing Off Pump Coronary Artery Bypass Grafting Surgery. Indian Journal of Anaesthesia, 59, 282-286. [Google Scholar] [CrossRef] [PubMed]
[20] Preckel, B. (2004) Haemodynamic Changes during Halothane, Sevoflurane and Desflurane Anaesthesia in Dogs before and after the Induction of Severe Heart Failure. European Jour-nal of Anaesthesiology, 21, 797-806. [Google Scholar] [CrossRef
[21] Cho, Y.J., et al. (2021) Effects of Anesthetics on Mi-crovascular Reactivity Measured by Vascular Occlusion Tests during Off-Pump Coronary Artery Bypass Surgery: A Randomized Controlled Trial. Journal of Clinical Monitoring and Computing, 35, 1219-1228. [Google Scholar] [CrossRef] [PubMed]
[22] Devereaux, P.J. and Szczeklik, W. (2020) Myocardial Injury af-ter Non-Cardiac Surgery: Diagnosis and Management. European Heart Journal, 41, 3083-3091. [Google Scholar] [CrossRef] [PubMed]
[23] Pagel, P.S. and Crystal, G.J. (2018) The Discovery of Myocardial Preconditioning Using Volatile Anesthetics: A History and Contemporary Clinical Perspective. Journal of Cardiotho-racic and Vascular Anesthesia, 32, 1112-1134. [Google Scholar] [CrossRef] [PubMed]
[24] Feijoo-Bandin, S., et al. (2013) Nesfatin-1 in Human and Murine Cardiomyocytes: Synthesis, Secretion, and Mobilization of GLUT-4. Endocrinology, 154, 4757-4767. [Google Scholar] [CrossRef] [PubMed]
[25] Palasz, A., et al. (2012) Nesfatin-1, a Unique Regulatory Neuropeptide of the Brain. Neuropeptides, 46, 105-112. [Google Scholar] [CrossRef] [PubMed]
[26] Fanelli, G., Berti, M., and Casati, A. (2006) Fast-Track Anaesthe-sia for Laparoscopic Cholecystectomy: A Prospective, Randomized, Multicentre, Blind Comparison of Desflu-rane-Remifentanil or Sevoflurane-Remifentanil. European Journal of Anaesthesiology, 23, 861-868. [Google Scholar] [CrossRef
[27] Ozdogan, H.K., et al. (2016) The Effects of Sevoflurane and Desflurane on the Hemodynamics and Respiratory Functions in Laparoscopic Sleeve Gastrectomy. Journal of Clinical Anesthesia, 35, 441-445. [Google Scholar] [CrossRef] [PubMed]
[28] Ryu, K.H., et al. (2018) Desflurane Reduces Intraoperative Remifentanil Requirements More than Sevoflurane: Comparison Using Surgical Pleth Index-Guided British Journal of Anaesthesia, 121, 1115-1122. [Google Scholar] [CrossRef] [PubMed]
[29] Müller-Edenborn, B., et al. (2015) Volatile Anaesthetics Reduce Neutrophil Inflammatory Response by Interfering with CXC Receptor-2 Signalling. British Journal of Anaesthesia, 114, 143-149. [Google Scholar] [CrossRef] [PubMed]
[30] Yamamoto, S., et al. (2020) Perioperative and Anesthetic Risk Factors of Surgical Site Infection in Patients Undergoing Pancreaticoduodenectomy: A Retrospective Cohort Study. PLOS ONE, 15, e0240490. [Google Scholar] [CrossRef] [PubMed]
[31] Yoon, H.K., et al. (2020) Anesthetic Agents and Cardiovascular Outcomes of Noncardiac Surgery after Coronary Stent Insertion. Journal of Clinical Medicine, 9, Article No. 429. [Google Scholar] [CrossRef] [PubMed]
[32] Park, J., et al. (2020) Volatile Versus Total Intravenous Anesthesia for 30-Day Mortality Following Non-Cardiac Surgery in Patients with Preoperative Myocardial Injury. PLOS ONE, 15, e0238661. [Google Scholar] [CrossRef] [PubMed]
[33] Kwon, J.H., et al. (2019) Effects of Volatile versus Total Intra-venous Anesthesia on Occurrence of Myocardial Injury after Non-Cardiac Surgery. Journal of Clinical Medicine, 8, 1999. [Google Scholar] [CrossRef
[34] Muhammet Gozdemir Huseyin Sert, N.Y., Kanbak, O. and Usta, B. (2007) Remifentanil-Propofol in Vertebral Disk Operations: Hemodynamics and Recovery versus Desflu-rane-N2O Inhalation Anesthesia. Advances in Therapy, 24, 622-631. [Google Scholar] [CrossRef
[35] Lu, C.H., et al. (2016) Faster Extubation Time with More Stable Hemodynamics during Extubation and Shorter Total Surgi-cal Suite Time after Propofol-Based Total Intravenous Anesthesia Compared with Desflurane Anesthesia in Lengthy Lumbar Spine Surgery. Journal of Neurosurgery: Spine, 24, 268-274. [Google Scholar] [CrossRef
[36] Zhao, P., et al. (2021) Inhalation of Low-Dose Desflurane Pre-vents the Hemodynamic Instability Caused by Target-Controlled Infusion of Remifentanil and Propofol during Laparo-scopic Gynecological Surgery: A Randomized Controlled Trial. Experimental and Therapeutic Medicine, 21, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[37] Crea, F. (2022) Inflammation, Targeted Proteomics, and Micro-vascular Dysfunction: The New Frontiers of Ischaemic Heart Disease. European Heart Journal, 43, 1517-1520. [Google Scholar] [CrossRef] [PubMed]
[38] Cho, Y.J., et al. (2017) Microcirculation Measured by Vascular Oc-clusion Test during Desflurane-Remifentanil Anesthesia Is Superior to That in Propofol-Remifentanil Anesthesia in Pa-tients Undergoing Thoracic Surgery: Subgroup Analysis of a Prospective Randomized Study. Journal of Clinical Moni-toring and Computing, 31, 989-997. [Google Scholar] [CrossRef] [PubMed]
[39] Pagel, P.S., Fu, J.L., Damask, M.C., et al. (1998) Desflurane and Isoflurane Produce Similar Alterations in Systemic and Pulmonary Hemodynamics and Arterial Oxygenation in Patients Undergoing One-Lung Ventilation during Thoracotomy. Anesthesia & Analgesia, 87, 800-807. [Google Scholar] [CrossRef
[40] Wang, J.Y., Russell, G.N., Page, R.D., et al. (2000) Ef-fect of Cricoid Pressure on the Incidence Ofnausea and Vomiting in the Immediate Postoperative Period. Anaesthesia, 55, 167-173. [Google Scholar] [CrossRef] [PubMed]
[41] Beaussier, M, Paugam, C., Deriaz, H., et al. (2000) Haemodynamic Stability during Moderate Hypotensive Anaesthesia for Spinal Surgery. A Comparison between Desflu-rane and Isoflurane. Acta Anaesthesiologica Scandinavica, 44, 1154-1159. [Google Scholar] [CrossRef] [PubMed]
[42] Lemoine, S., et al. (2010) Bradykinin and Adenosine Re-ceptors Mediate Desflurane Induced Postconditioning in Human Myocardium: Role of Reactive Oxygen Species. BMC Anesthesiology, 10, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[43] Sedlic, F., et al. (2009) Differences in Production of Reactive Oxy-gen Species and Mitochondrial Uncoupling As Events in the Preconditioning Signaling Cascade between Desflurane and Sevoflurane. Anesthesia & Analgesia, 109, 405-411. [Google Scholar] [CrossRef] [PubMed]
[44] Laver, D.R., et al. (2017) Cardiac Calcium Release Channel (Ryanodine Receptor 2) Regulation by Halogenated Anesthetics. Anesthesiology, 126, 495-506. [Google Scholar] [CrossRef
[45] Gao, S., et al. (2016) Diabe-tes Blocks the Cardioprotective Effects of Sevoflurane Postconditioning by Impairing Nrf2/Brg1/HO-1 Signaling. Euro-pean Journal of Pharmacology, 779, 111-121. [Google Scholar] [CrossRef] [PubMed]
[46] Zheng, Y., Lu, H. and Huang, H. (2020) Desflurane Precondi-tioning Protects against Renal Ischemia-Reperfusion Injury and Inhibits Inflammation and Oxidative Stress in Rats Through Regulating the Nrf2-Keap1-ARE Signaling Pathway. Drug Design, Development and Therapy, 14, 1351-1362. [Google Scholar] [CrossRef
[47] Rosenberg, J.H., et al. (2018) Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning. Journal of Cardiovascular Translational Research, 11, 292-307. [Google Scholar] [CrossRef] [PubMed]
[48] Loor, G., et al. (2011) Mitochondrial Oxidant Stress Triggers Cell Death in Simulated Ischemia-Reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1813, 1382-1394. [Google Scholar] [CrossRef] [PubMed]
[49] Lemoine, S., et al. (2011) Mechanisms Involved in the Desflu-rane-Induced Post-Conditioning of Isolated Human Right Atria from Patients with Type 2 Diabetes. British Journal of Anaesthesia, 107, 510-518. [Google Scholar] [CrossRef] [PubMed]
[50] Stumpner, J., et al. (2012) Desflurane-Induced and Ischaemic Postcondi-tioning against Myocardial Infarction Are Mediated by Pim-1 Kinase. Acta Anaesthesiologica Scandinavica, 56, 904-913. [Google Scholar] [CrossRef] [PubMed]
[51] Lin, S., Neelankavil, J. and Wang, Y. (2021) Cardioprotec-tive Effect of Anesthetics: Translating Science to Practice. Journal of Cardiothoracic and Vascular Anesthesia, 35, 730-740. [Google Scholar] [CrossRef] [PubMed]
[52] Hanna, A. and Frangogiannis, N.G. (2020) Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure. Cardiovascular Drugs and Therapy, 34, 849-863. [Google Scholar] [CrossRef] [PubMed]
[53] Baki, E.D., et al. (2013) Comparison of the Effects of Desflurane and Propofol Anesthesia on the Inflammatory Response and S100beta Protein during Coronary Artery Bypass Grafting. Inflammation, 36, 1327-1333. [Google Scholar] [CrossRef] [PubMed]
[54] Sun, Z., et al. (2015) Desflurane Preconditioning Protects Human Umbilical Vein Endothelial Cells against Anoxia/Reoxygenation by Upregulating NLRP12 and Inhibiting Non-Canonical Nuclear Factor-κB Signaling. International Journal of Molecular Medicine, 36, 1327-1334. [Google Scholar] [CrossRef] [PubMed]
[55] Li, Y., et al. (2008) Desflurane Preconditioning Inhibits Endothelial Nuclear Factor-Kappa-B Activation by Targeting the Proximal End of Tumor Necrosis Factor-Alpha Signaling. Anesthe-sia & Analgesia, 106, 1473-1479. [Google Scholar] [CrossRef] [PubMed]
[56] Hong, L., et al. (2020) Sevoflurane Preconditioning Confers Delayed Cardioprotection by Upregulating AMP-Activated Protein Kinase Levels to Restore Autophagic Flux in Ische-mia-Reperfusion Rat Hearts. Medical Science Monitor, 26, e922176. [Google Scholar] [CrossRef
[57] Li, J.Y., et al. (2021) A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis. Frontiers in Cell and Developmental Biology, 9, Article ID: 799499. [Google Scholar] [CrossRef] [PubMed]
[58] Ward, Z., et al. (2021) Novel and Annotated Long Noncoding RNAs Associated with Ischemia in the Human Heart. International Journal of Molecular Sciences, 22, Article No. 11324. [Google Scholar] [CrossRef] [PubMed]
[59] Jin, G., et al. (2022) LncRNA UCA1 Epigenetically Sup-presses APAF1 Expression to Mediate the Protective Effect of Sevoflurane against Myocardial Ischemia-Reperfusion Injury. Functional & Integrative Genomics. [Google Scholar] [CrossRef] [PubMed]
[60] Liu, X., et al. (2016) Circulating MicroRNAs Indicate Cardio-protection by Sevoflurane Inhalation in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery. Experimental and Therapeutic Medicine, 11, 2270-2276. [Google Scholar] [CrossRef] [PubMed]